| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/27/2005 | EP1556484A2 Cytoplasmic dynein heavy chain 1 genes, expression products, non-human animal model: uses in human neurological diseases |
| 07/27/2005 | EP1556482A1 Novel polypeptide having function of 7-keto-8-aminopelargonic acid synthase of plant and method for inducing growth inhibition and lethality by suppressing expression of the polypeptide |
| 07/27/2005 | EP1556478A2 High sensitivity quantitation of peptides by mass spectrometry |
| 07/27/2005 | EP1556411A2 Viral vectors and the use of the same for gene therapy |
| 07/27/2005 | EP1556410A2 Peptide fragments of the harp factor inhibiting angiogenesis |
| 07/27/2005 | EP1556409A1 Soluble truncated polypeptides of the nogo-a protein |
| 07/27/2005 | EP1556408A1 Membrane protein library for proteome analysis and method for preparing same |
| 07/27/2005 | EP1556402A2 In vivo gene silencing by chemically modified and stable sirna |
| 07/27/2005 | EP1556401A2 22 human secreted proteins |
| 07/27/2005 | EP1556089A2 Inhibition of gene expression using rna interfering agents |
| 07/27/2005 | EP1556088A2 Compositions for cancer treatment |
| 07/27/2005 | EP1556076A2 Apo-2 ligand/trail variants and uses thereof |
| 07/27/2005 | EP1556070A2 Delocalization molecules and use thereof |
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1555874A2 Gene regulation with aptamer and modulator complexes for gene therapy |
| 07/27/2005 | EP1555870A2 Methods and compositions for production of flavonoid and isoflavonoid nutraceuticals |
| 07/27/2005 | EP1438397A4 Plant reproduction polynucleotides and methods of use |
| 07/27/2005 | EP1412537A4 Cardiotoxin molecular toxicology modeling |
| 07/27/2005 | EP1283878B1 Receptor-based interaction trap |
| 07/27/2005 | EP1253364B1 Ultralow expansion brake rubber hose and its production method |
| 07/27/2005 | EP1206539B1 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 07/27/2005 | EP1086240A4 Methods for testing biological network models |
| 07/27/2005 | EP1025236B1 Human checkpoint kinase, hcds1, compositions and methods |
| 07/27/2005 | EP0990000B1 Connective tissue growth factor-3 |
| 07/27/2005 | EP0977848B1 Human theta subunit of the gaba-a receptor |
| 07/27/2005 | EP0952855B1 Use of hyaluronan in gene therapy |
| 07/27/2005 | EP0920510B1 GnRH-LEUKOTOXIN CHIMERAS |
| 07/27/2005 | EP0682707B1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 07/27/2005 | EP0438512B2 Process for analysing length polymorphisms in dna domains |
| 07/27/2005 | CN1646917A Method of identifying transmembrane protein-interacting compounds |
| 07/27/2005 | CN1646908A Multi-functional microarrays and methods |
| 07/27/2005 | CN1646906A Disruption of the REDK gene |
| 07/27/2005 | CN1646706A Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays |
| 07/27/2005 | CN1646705A Amplification-hybridisation method for detecting and typing human papillomavirus |
| 07/27/2005 | CN1646703A Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 07/27/2005 | CN1646702A Protein carrier system for therapeutic oligonucleotides |
| 07/27/2005 | CN1646701A Method and test kit for demonstrating genetic identity |
| 07/27/2005 | CN1646697A Process control based on microbiological activity |
| 07/27/2005 | CN1646695A Use of the AXL receptor for diagnosis and treatment of renal disease |
| 07/27/2005 | CN1646694A Over-expression of extremozyme genes in pseudomonads and closely related bacteria |
| 07/27/2005 | CN1646693A Enveloped microorganism |
| 07/27/2005 | CN1646692A Genetic products differentially expressed in tumors and use thereof |
| 07/27/2005 | CN1646691A Enhancer sequence of the 5-aminolevulinic acid synthase gene |
| 07/27/2005 | CN1646690A Genes coding for glucose-6-phosphate-dehydrogenase proteins |
| 07/27/2005 | CN1646689A Novel scavenger receptors |
| 07/27/2005 | CN1646688A Growth regulating proteins |
| 07/27/2005 | CN1646687A Modified gene-silencing RNA and uses thereof |
| 07/27/2005 | CN1646686A Novel promoters |
| 07/27/2005 | CN1646684A Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 07/27/2005 | CN1646683A Host cells having improved cell survival properties and methods to generate such cells |
| 07/27/2005 | CN1646680A Promoter and plasmid system for genetic engineering |
| 07/27/2005 | CN1646567A Anti-idiotype anti-CEA antibody molecules and its use as cancer vaccine |
| 07/27/2005 | CN1646564A 修饰的因子Ⅷ Modification factor Ⅷ |
| 07/27/2005 | CN1646563A Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/27/2005 | CN1646562A Pluripotency determining factors and uses thereof |
| 07/27/2005 | CN1646561A Gene conferring resistance to phytophthora infestans (late-blight) in solanacea |
| 07/27/2005 | CN1646560A Nucleotide sequence coding for a ToIC containing a heterologous amino acid sequence |
| 07/27/2005 | CN1646557A Nucleic acid separation and detection by electrophoresis with a counter-migrating high-affinity intercalating dye |
| 07/27/2005 | CN1646452A Methods of producing phosphitylated compounds |
| 07/27/2005 | CN1646161A Reagents and treatment methods for autoimmune diseases |
| 07/27/2005 | CN1646160A Anti-alpha V beta 6 antibodies |
| 07/27/2005 | CN1646157A Multiple and multivalent DNA vaccines in ovo |
| 07/27/2005 | CN1646154A Albumin-fused anti-angiogenesis peptides |
| 07/27/2005 | CN1646153A Active antiangiogenic therapy |
| 07/27/2005 | CN1646097A Chemosensitizing with liposomes containing oligonucleotides |
| 07/27/2005 | CN1646022A Method of improving dough and bread quality |
| 07/27/2005 | CN1646006A Novel VIP3 toxins and methods of use |
| 07/27/2005 | CN1646005A Plant with improved organogenesis and method of constructing the same |
| 07/27/2005 | CN1645401A Information processing system using nucleotide sequence-related information |
| 07/27/2005 | CN1644708A Mycobacterium tuberculosis superoxide dismutase |
| 07/27/2005 | CN1644706A Clone procaryotic biological salt-resistant related gene method |
| 07/27/2005 | CN1644702A Visuble self-sucking extrinsic gene induction of insect egg |
| 07/27/2005 | CN1644701A Tumour cell specific eucaryon expressing carriers |
| 07/27/2005 | CN1644700A Plasmid with bar streptomycete Lat gene loss, derivative and constructing method thereof |
| 07/27/2005 | CN1644699A Preparation for plant metal surfur protein |
| 07/27/2005 | CN1644698A Nucleotide sequence of pichia delta12-fatty acid dehydrogenase and its use |
| 07/27/2005 | CN1644697A Thioredoxin peroxidase gene of China Qingdao branchiostoma and use thereof |
| 07/27/2005 | CN1644696A Genes coding for flavone synthases |
| 07/27/2005 | CN1644695A P450BM-3 variant gene for catalyzing indigo blue generated by benzazole and and use thereof |
| 07/27/2005 | CN1644694A Banana fruit differential high efficient starter and plant expressing carrier |
| 07/27/2005 | CN1644693A Protein having tpo activity |
| 07/27/2005 | CN1644692A Hippocampus protease inhibitor gene and its use |
| 07/27/2005 | CN1644691A Human epidermis factor nucleic sequence and use thereof |
| 07/27/2005 | CN1644690A Gene encoding protein having aurone synthesizing activity |
| 07/27/2005 | CN1644689A Promoters and usage thereof |
| 07/27/2005 | CN1644688A Preparation of human mast cell protaminaase hMC-CP |
| 07/27/2005 | CN1644687A Organophosphorus degradating enzyme and coding gene |
| 07/27/2005 | CN1644686A High yielded strain of mammalia influenza virus, its recommbined strains and preparation and use thereof |
| 07/27/2005 | CN1644679A Hydrogen generating bacteria and its screening method |
| 07/27/2005 | CN1644676A Phytase generating gene-engineering bacteria and its culture |
| 07/27/2005 | CN1644674A Membrane forming bacteria agent for biologic membrane and method for structuring and analyzing membrane |
| 07/27/2005 | CN1644586A Oxydiertes thymosin beta 4 |
| 07/27/2005 | CN1644585A Covalently linked oligonucleotide minor grove binder conjugates |
| 07/27/2005 | CN1212402C Multi copy yeast expression carrier for proceeding correct secretory expression against exogenous gene |
| 07/27/2005 | CN1212401C Plant virus satellite DNA beta molecule, infectivity clone and method for preparing expression carrier |
| 07/27/2005 | CN1212400C Method for obtaining transgenic rape chloroplast plant for producing foot-and-mouth disease vaccine |
| 07/27/2005 | CN1212399C Method for obtaining transgenic mountain lettuce chloroplast plant for producing foot-and-mouth disease vaccine |
| 07/27/2005 | CN1212398C Novel IFN receptor 1 binding proteins, DNA encoding them, and method of modulating cellular response to interferons |
| 07/27/2005 | CN1212397C Screening non-infective virus recombinant gene SARS-Cov-EGFP for medicine of anti-SARS coronavirus |
| 07/27/2005 | CN1212395C Mutation alpha-amylase |